Cystic fibrosis: A look into the future of prenatal screening and therapy

E-ISSN： 1542-9768|105|1|73-80

ISSN： 1542-975X

Source： Birth Defects Research. Part C: Embryo Today Reviews, Vol.105, Iss.1, 2015-03, pp. : 73-80

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Is Cystic Fibrosis Carrier Screening Cost Effective?

Public Health Genomics, Vol. 10, Iss. 2, 2007-03 ,pp. : 103-109

Karger

Access to resources Recommend Favorite

Cystic fibrosis in an era of genomically guided therapy

By Barrett P.M. Alagely A. Topol E.J.

Human Molecular Genetics, Vol. 22, Iss. 9, 2013-05 ,pp. : 1911-1911

Oxford University Press

Access to resources Recommend Favorite

Population-Based Genetic Screening for Cystic Fibrosis: Attitudes and Outcomes

Public Health Genomics, Vol. 13, Iss. 7-8, 2010-01 ,pp. : 449-456

Karger

Access to resources Recommend Favorite

Assessing the Potential Success of Cystic Fibrosis Carrier Screening: Lessons Learned from Tay-Sachs Disease and β-Thalassemia

Public Health Genomics, Vol. 13, Iss. 5, 2009-10 ,pp. : 310-319

Karger

Access to resources Recommend Favorite

Preconceptional Screening of Couples for Carriers of Cystic Fibrosis: A Prospective Evaluation of Effects, Costs and Savings for Different Mutation Detection Methods

Public Health Genomics, Vol. 2, Iss. 2-3, 2000-03 ,pp. : 74-81

Karger

Access to resources Recommend Favorite